Short-term Effects of Nortriptyline on Sleep Parameters for Residual OSA after UPPP.
This trial suggests that nortriptyline may be a promising treatment option for improving residual sleep apnea in patients who have already undergone UPPP but still experience symptoms. Further research is needed to confirm these initial results. Trial registration number: IRCT20230614058482N1.
Authors
- Reza Hosseini
- Pedram Borghei (ORCID: https://orcid.org/0000-0002-6506-7500)
- Reza Erfanian (ORCID: https://orcid.org/0000-0001-8147-5320)
- Reihaneh Heidari
- Amin Amali (ORCID: https://orcid.org/0000-0001-5718-7150)
Institutions
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.22038/ijorl.2025.87813.3947
- Primary Topic
- Obstructive Sleep Apnea Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Tehran University of Medical Sciences and Health Services